Rocket Pharmaceuticals (RCKT) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Q3 2025 value amounting to -$0.45.
- Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) rose 3661.97% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.25, marking a year-over-year increase of 1758.24%. This contributed to the annual value of -$2.73 for FY2024, which is 653.55% up from last year.
- Latest data reveals that Rocket Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.45 as of Q3 2025, which was up 3661.97% from -$0.62 recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.45 during Q3 2025, and its lowest value of -$0.89 during Q4 2022.
- In the last 5 years, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.68 in 2021 and averaged -$0.7.
- As far as peak fluctuations go, Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 3761.47% in 2021, and later tumbled by 5090.91% in 2022.
- Quarter analysis of 5 years shows Rocket Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.68 in 2021, then tumbled by 30.88% to -$0.89 in 2022, then skyrocketed by 30.34% to -$0.62 in 2023, then decreased by 2.63% to -$0.64 in 2024, then increased by 29.28% to -$0.45 in 2025.
- Its last three reported values are -$0.45 in Q3 2025, -$0.62 for Q2 2025, and -$0.56 during Q1 2025.